--- title: Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy description: InsightRX's partnership with Healix helps patients maximize the therapeutic benefit of their home infusions while minimizing the risk of adverse events image: https://blog.insight-rx.com/hubfs/Healix-Logos_Primary-Blu-300dpi-1.png --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/) - For Providers - Solutions - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd) - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future) - Products - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova) - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo) - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules) - [For Life Sciences](https://www.insight-rx.com/life-sciences) - Overview - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences) - Products - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova) - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra) - Platform - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning) - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support) - Resources - Science - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science) - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications) - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova) - Explore - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories) - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers) - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software) - [Blog](https://blog.insight-rx.com/resources) - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources) - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership) - Company - About - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about) - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership) - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board) - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers) - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers) - Press - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases) - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) Press Releases # Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy - Published August 9, 2022 By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx) ![](https://blog.insight-rx.com/hubfs/Healix-Logos_Primary-Blu-300dpi-1.png) SAN FRANCISCO, August 09, 2022 – Today InsightRX, a high-growth healthcare technology company that provides cloud-based clinical decision support for point-of-care precision dosing, announced its partnership with Healix, the national leader in physician office-based infusion services. InsightRX uses patient-specific data, pharmacokinetic/ pharmacodynamic (PK/PD) models, and Bayesian forecasting to deliver precision dosing guidance based on each patient’s unique pharmacological profile. Healix provides in-office infusion management services for the intravenous administration of outpatient parenteral antimicrobial therapy (OPAT) to a patient population with a range of conditions, including complicated skin infections and bone and joint infections, with or without Methicillin-resistant Staphylococcus aureus (MRSA) infection. InsightRX Nova, the company’s clinical decision support tool for prospective dosing, guides physicians in determining the optimal initial dose for each patient. The tool uses patient-specific exposure metrics to help physicians tailor the dosing regimen as treatment progresses. The InsightRX precision dosing platform now supports more than 2,000 physicians and 300 infusion clinics across the country, and is available across the entire Healix enterprise. Since implementing InsightRX Nova in April 2021, Healix sites have seen low rates of acute kidney injury, ensuring patient safety. > “Our partnership with InsightRX allows us to offer best-in-class precision dosing support to help our physician clients make evidence-based decisions for safer, more effective treatment,” said Lucinda Van Anglen, Vice President of Clinical Pharmacy and Research at Healix. “By replacing trough-based dosing with MAP-Bayesian analysis for AUC/MIC vancomycin dosing, we’re meeting new national recommendations to help ensure patient safety and improve clinical outcomes.” In addition to individualized dosing guidance, InsightRX will also provide Healix with real-time analytics to help the organization monitor its performance and conduct site-specific validation of the best pharmacokinetic model for each drug. By analyzing which model returns the most precise predictions of a patient’s drug concentration levels in the blood, Healix and InsightRX will embark on a cycle of continual quality improvement to fine-tune best practices in dosing administration. > “We’re excited to work side-by-side with Healix to further our shared mission of achieving superior clinical outcomes,” said Sirj Goswami, PhD, CEO and Co-Founder of InsightRX. “As precision medicine becomes more widely recognized as the standard-bearer for evidence-based care, we expect that more and more healthcare markets will adopt model-informed precision dosing. Partnering with Healix lets us help patients maximize the therapeutic benefit of their home infusions while minimizing the risk of adverse events.” About Healix As the premier provider of outpatient infusion management services, [Healix](https://healix.net/) has provided patient and physician peace of mind for more than 30 years. With more than 300 infusion clinics across the country, Healix specializes in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology. The Healix team serves as an extension of the physician’s practice, optimizing patient care, comfort, compliance, and clinical outcomes in an outpatient setting. Clients rely on Healix to handle complete infusion center operations, including drug purchasing, revenue cycle management, managed care programs, and clinical staffing. [implementation](https://blog.insight-rx.com/press-releases/tag/implementation) [partnerships](https://blog.insight-rx.com/press-releases/tag/partnerships) [home infusion](https://blog.insight-rx.com/press-releases/tag/home-infusion) #### On this page… **Connect with us to get the latest blog updates, instantly sent to your inbox** ## Dig deeper. Explore related articles and additional posts on the InsightRX blog. [Press Releases Oct 8, 2024 InsightRX to Present Three Abstracts Demonstrating Advances in Bayesian Precision Dosing at IDWeek 2024](https://blog.insight-rx.com/press-releases/insightrx-abstracts-idweek-2024-bayesian-precision-dosing) [Press Releases Mar 13, 2019 InsightRX And Children's Hospital Los Angeles (CHLA) To Partner On Precision Dosing](https://blog.insight-rx.com/press-releases/chla-bestdose-partners-precision-dosing) [Press Releases Oct 7, 2025 InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution](https://blog.insight-rx.com/press-releases/insightrx-klas-spotlight-report) #### What We Do ##### For Providers - [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova) - [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo) - [Drug Modules](https://www.insight-rx.com/provider/drug-modules) ##### For Life Sciences - [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova) - [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra) - [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications) #### How We Do It ##### Platform - [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning) - [Integrations](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support](https://www.insight-rx.com/platform/success-support) ##### Science - [Data Science](https://www.insight-rx.com/data-science) - [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications) #### Information ##### Resources - [Success Stories](https://www.insight-rx.com/success-stories) - [White Papers](https://www.insight-rx.com/white-papers) - [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software) - [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova) ##### Blog - [All Posts](https://blog.insight-rx.com/resources) - [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership) #### About - [Our Story](https://www.insight-rx.com/about) - [Leadership](https://www.insight-rx.com/leadership) - [Advisory Board](https://www.insight-rx.com/advisory-board) - [Our Customers](https://www.insight-rx.com/customers) - [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media](https://blog.insight-rx.com/press-releases?section=media) - [Careers](https://www.insight-rx.com/careers) - [Contact](https://www.insight-rx.com/contact-us) --- ![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg) InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1. InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance. 740-05000-REC-01 · 08/2025 --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/) 548 Market Street #88083 San Francisco, CA 94104 --- © 2026 InsightRX, Inc. All rights reserved. [Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InsightRX Communications", "url" : "https://blog.insight-rx.com/press-releases/author/insightrx" }, "dateModified" : "2025-12-15T02:36:49.814Z", "datePublished" : "2022-08-09T16:07:00.000Z", "headline" : "Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy", "image" : [ "https://blog.insight-rx.com/hubfs/Healix-Logos_Primary-Blu-300dpi-1.png" ], "mainEntityOfPage" : { "@id" : "https://blog.insight-rx.com/press-releases/healix-insightrx-provide-patient-specific-precision-dosing-outpatient-infusion-therapy", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png" }, "name" : "InsightRX" } } ```